GL1X · GenesisL1 explorer

MolNFT v1 · #172553 · protein

Crystal structure of L1 with hydrolyzed faropenem (imine, ring-closed form)

7A63 · Metallo-beta-lactamase L1: “Crystal structure of L1 with hydrolyzed faropenem (imine, ring-closed form)”. X-ray diffraction, 3 ligands (R3N, ZN, SO4), 2 pockets (best druggability 0.42). MolNFT v1 #172553 on GenesisL1: 3D structure…

PDB
7A63
Type
protein
Length
266 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Metallo-beta-lactamase L1
EC
3.5.2.6
UniProt
P52700
Ligands
R3N, ZN, SO4
Pockets
2 · best druggability 0.42

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMetallo-beta-lactamase L1 (EC 3.5.2.6)protein26631% helix, 24% strandP52700

Ligands and binding sites

  • R3N · (2R,5S)-2-[(1S,2R)-1-carboxy-2-hydroxy-propyl]-5-[(2R)-tetrahydrofuran-2-yl]-2,5-dihydrothiazole-4-carboxylic acid · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11200.420.7626ZN, R3N
2610.300.7419SO4

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 7A63 · Crystal structure of L1 with hydrolyzed faropenem (imine, ring-closed form) · the same entry in another collection · chain A against A, TM-score 1.00
  • P52700 · AlphaFold monomer V2.0 prediction for metallo-beta-lactamase L1 type 3 (P52700) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.